Table 4 Demographic and baseline characteristics of simulated study population.
Characteristic | Gef+C (n=174) | Gef (n=176) |
|---|---|---|
Age (years) | ||
Median (Range) | 54 (27-75) | 56 (27-78) |
Sex, Male, n (%) | 88 (51%) | 93 (53%) |
Smoking History, n (%) | ||
Never | 145 (83%) | 150 (85%) |
Former | 19 (11%) | 21 (12%) |
Current | 10 (6%) | 5 (3%) |
ECOG Performance Status, n (%) | ||
0 | 1 (1%) | 7 (4%) |
1 | 137 (79%) | 130 (74%) |
2 | 36 (21%) | 39 (22%) |
Comorbidities, n (%) | ||
None | 97 (56%) | 81 (46%) |
Hypertension | 21 (12%) | 32 (18%) |
Diabetes Mellitus | 9 (5%) | 9 (5%) |
COPD/Emphysema | 8 (5%) | 5 (3%) |
Prior Tuberculosis | 4 (2%) | 5 (3%) |
Multiple Comorbidities | 23 (13%) | 35 (20%) |
Histology, n (%) | ||
Adenocarcinoma | 170 (98%) | 170 (97%) |
Adenosquamous | 3 (2%) | 4 (2%) |
Squamous Cell Carcinoma | 1 (1%) | 1 (1%) |
Sarcomatoid Carcinoma | 0 (0%) | 1 (1%) |
Disease Stage, n (%) | ||
IV | 171 (98%) | 171 (97%) |
IIIB | 3 (2%) | 5 (3%) |
Metastatic Site, n (%) | ||
Pleura/Pericardium | 30 (17%) | 25 (14%) |
Opposite Lung | 20 (12%) | 18 (10%) |
Nonregional Lymph Nodes | 2 (1%) | 5 (3%) |
Bones | 24 (14%) | 25 (14%) |
Brain | 2 (1%) | 13 (7%) |
Liver | 1 (1%) | 2 (1%) |
Multiple Sites | 90 (52%) | 83 (47%) |
